Form EFFECT Kezar Life Sciences,
| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | February 10, 2025 4:00 P.M. |
| Form: | S-3 | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Pepeto Announces Presale Nearing Sellout as the Solana Price Prediction Targets $250 and SOL Whale Wallets Load Before the Bull Run
- FIBI Vacation Rentals Invites Estate Owners to Turn Their Properties into Income with New Short-Term Rental Underwriting Program
- Tron Price Prediction Strengthens as Network Hits 26 Million Active Accounts and Pepeto Presale Nears Listing
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share